Manufacturers. Promptly after obtaining actual knowledge thereof, notice of any Manufacturer Event of Default or termination or replacement of a Manufacturer Program;
Manufacturers. Furnish, or cause to be furnished to the Series 2007-1 Letter of Credit Provider, promptly after obtaining actual knowledge thereof, notice of any Manufacturer Event of Default or termination or replacement of an Eligible Vehicle Disposition Program;
Manufacturers. Subject to compliance with requirements, provide products by one of the following:
Manufacturers. Where specification paragraphs or subparagraphs titled “Manufacturers” provide a list of manufacturers’ names, Design-Builder must provide a product by one of the manufacturers listed that complies with the requirements of the specification.
Manufacturers. The manufacturers listed in this bid are the only manufacturers that will be considered. Do not offer alternate manufacturers as they will not be considered for contract award.
Manufacturers. Licensee agrees that at no time during the license or sell-off periods shall it sell, directly or indirectly, to any of the Manufacturers listed below, or to any individual or entity affiliated in any manner with any of such Manufacturers, any Licensed Product(s) for subsequent sale or distribution, without prior written approval of Licensor.
Manufacturers i. If Participant utilizes multiple manufacturing locations, annually, with a minimum of 24 hours’ notice, Validator will visit 20% of Participants’ manufacturing location(s) and randomly select 20% of the products submitted initially, for testing and certification. Sampled products will be treated with full F1292 (three-temperature) protocol. During the visit, a test to determine acceptable limits of the presence of tramp metals will be performed on a sample per F2075, Sections 4.6 & 9. Sample material will be selected for the hazardous materials test (4.5 & 8), along with sieve testing (4.4 and 7), and sent to the validating laboratory for additional tests required per ASTM F2075.
Manufacturers i. In addition to the sample selection process outlined in Section 4.3.3 of this Surfacing Procedural Guide, Validator will annually select 20% of the Participant’s crew chiefs, and randomly select one installation for testing per ASTM F3313 (Section 14 – Installed Surface Performance Test Procedure) at the equipment fall height.
Manufacturers. 1. Tandus-Centiva
Manufacturers. IDRI shall not enter into any agreement for the manufacture of IDRI GLA for IDRI by a Third Party manufacturer, other than (a) with respect to limited-quantity production for purposes of evaluation by IDRI of the manufacturer, and/or by the manufacturer of IDRI, as to the propriety of IDRI’s engaging such manufacturer and (b) in instances in which a prior notice under this Section has been given by IDRI to Immune Design with respect to the same manufacturer or one of its Affiliates, unless IDRI has first obtained Immune Design’s approval of such manufacturer for such purpose, which approval (i) shall not be unreasonably withheld or delayed and (ii) shall not in any case be withheld or delayed based on any reason other than a Deficiency, as defined below. Upon receipt of such notice, Immune Design shall have a period of *** days in which either to approve such manufacturer or to provide to IDRI a written statement of reasons, based upon all reasonably available information (which shall be stated in such notice by Immune Design) believed by Immune Design in good faith to be credible and to bear directly upon a Deficiency applicable to such manufacturer (a “Deficiency Statement”). If Immune Design does not deliver any such Deficiency Statement within such ***-day period, it shall be deemed to have approved the manufacturer. Any disputes under this provision as to the propriety of any Deficiency Statement shall be promptly resolved pursuant to Section 13.2 without the requirement to attempt to first resolve the dispute under Section 13.1; provided, however, that ***. Any such resolution finding that Immune Design’s Deficiency Statement was erroneous or otherwise unreasonable shall constitute an approval of the manufacturer by Immune Design for purposes of this Section. If the parties fail to agree on *** within *** days after the dispute is referred to arbitration, then *** pursuant to the arbitration rules referenced in Section 13.2; provided, that ***. As used herein, “Deficiency” means any of the following: ***. For clarity, no geographical, cultural, commercial or competitive consideration that is not founded upon the considerations listed in clauses *** above will be eligible to be a Deficiency.
